Page results
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Prime Minister Boris Johnson visited the vaccination centre at the Islington Business Design Centre yesterday.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.
-
UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
The children and young people's division at UCLH are running two events for young people aged 13 - 24 years.
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
This page tells you about the procedure known as a renal cryoablation. It explains what is involved and what the possible risks are.
File results
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy